Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
SaleCommon Stock | 25,000 | $62.79 | $1,569,790.00 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · nonDerivative · entry 5 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,225 F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting person's 401(k) Plan as of January 19, 2005. Read SEC document |
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
SaleCommon Stock | 25,000 | $62.65 | $1,566,277.50 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · nonDerivative · entry 4 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,225 F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting person's 401(k) Plan as of January 19, 2005. Read SEC document |
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
SaleCommon Stock | 29,340 | $62.56 | $1,835,522.14 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · nonDerivative · entry 3 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,225 F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting person's 401(k) Plan as of January 19, 2005. Read SEC document |
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
GiftCommon Stock | 3,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · nonDerivative · entry 2 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,565 F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting person's 401(k) Plan as of January 19, 2005. Read SEC document |
| February 01, 2005 Filed Feb 2, 2005 18:22 UTC |
FRITZKY EDWARD VDirector
|
Exercise / conversionCommon Stock | 208,000 | $57.94 | $12,051,520.00 |
DisclosureSEC source: 0001181431-05-006322 · rrd66932.xml · nonDerivative · entry 1 FRITZKY EDWARD V · CIK 0001187892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (EVF 1.19.05) Does not include (i) 528 shares indirectly held by report person's son, (ii) 528 shares indirectly held by reporting person's daughter, and (iii) 5,677 shares indirectly held by reporting person's 401(k) Plan as of January 19, 2005. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:36 UTC |
BONANNI FABRIZIOSenior VP, Manufacturing
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $39.03 | $0.00 |
DisclosureSEC source: 0001181431-05-005944 · rrd66713.xml · derivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,190 Underlying: Common Stock · 35,000 shares Expires 2006-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:36 UTC |
BONANNI FABRIZIOSenior VP, Manufacturing
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001181431-05-005944 · rrd66713.xml · derivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2006-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:36 UTC |
BONANNI FABRIZIOSenior VP, Manufacturing
|
SaleCommon Stock | 39,000 | $61.95 | $2,415,855.00 |
DisclosureSEC source: 0001181431-05-005944 · rrd66713.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,130 F1 · balance_after: (FB 01/05) The reporting person no longer has a reportable beneficial interest in 550 shares of Amgen Inc. common stock owned by his daughter and 550 shares of Amgen Inc. common stock owned by his son and included in the reporting person's prior ownership reports. In addition, does not include 6,901 shares held indirectly by reporting person's trust. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:36 UTC |
BONANNI FABRIZIOSenior VP, Manufacturing
|
Exercise / conversionCommon Stock | 4,000 | $30.44 | $121,750.00 |
DisclosureSEC source: 0001181431-05-005944 · rrd66713.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (FB 01/05) The reporting person no longer has a reportable beneficial interest in 550 shares of Amgen Inc. common stock owned by his daughter and 550 shares of Amgen Inc. common stock owned by his son and included in the reporting person's prior ownership reports. In addition, does not include 6,901 shares held indirectly by reporting person's trust. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:36 UTC |
BONANNI FABRIZIOSenior VP, Manufacturing
|
Exercise / conversionCommon Stock | 35,000 | $39.03 | $1,366,095.50 |
DisclosureSEC source: 0001181431-05-005944 · rrd66713.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (FB 01/05) The reporting person no longer has a reportable beneficial interest in 550 shares of Amgen Inc. common stock owned by his daughter and 550 shares of Amgen Inc. common stock owned by his son and included in the reporting person's prior ownership reports. In addition, does not include 6,901 shares held indirectly by reporting person's trust. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:37 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
GiftCommon Stock | 165 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-005945 · rrd66710.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,587 F1 · balance_after: (DMF 1/05) Does not include (i) 20,000 shares of Amgen Inc. Common Stock directly held by the reporting person and (ii) 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| January 28, 2005 Filed Mar 8, 2005 18:17 UTC |
JOHNSON FRANKLIN P JRDirector
|
GiftCommon Stock | 644,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-015244 · rrd71671.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 644,000 F1 · kind: (FPJ 3.07.05) Shares are being transferred to the Johnson Revocable Trust dated June 25, 2003. Read SEC document |
| January 28, 2005 Filed Mar 8, 2005 18:17 UTC |
JOHNSON FRANKLIN P JRDirector
|
GiftCommon Stock | 644,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-015244 · rrd71671.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 178,888 F1 · kind: (FPJ 3.07.05) Shares are being transferred to the Johnson Revocable Trust dated June 25, 2003. Read SEC document |
| January 19, 2005 Filed Jan 19, 2005 21:21 UTC |
OMENN GILBERT SDirector
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 18,400 | $0.00 Strike: $7.67 | $0.00 |
DisclosureSEC source: 0001181431-05-003557 · rrd65219.xml · derivative · entry 3 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,400 shares Expires 2005-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2005 Filed Jan 19, 2005 21:21 UTC |
OMENN GILBERT SDirector
|
Tax withholdingCommon Stock | 2,200 | $64.16 | $141,152.00 |
DisclosureSEC source: 0001181431-05-003557 · rrd65219.xml · nonDerivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,011 F1 · balance_after: (GSO-12.09.04) Does not include .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| January 19, 2005 Filed Jan 19, 2005 21:21 UTC |
OMENN GILBERT SDirector
|
Exercise / conversionCommon Stock | 18,400 | $7.67 | $141,162.96 |
DisclosureSEC source: 0001181431-05-003557 · rrd65219.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (GSO-12.09.04) Does not include .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| January 10, 2005 Filed Jan 12, 2005 18:17 UTC |
JOHNSON FRANKLIN P JRDirector
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 18,400 | $0.00 Strike: $7.67 | $0.00 |
DisclosureSEC source: 0001181431-05-002559 · rrd64401.xml · derivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,400 shares Expires 2005-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2005 Filed Jan 12, 2005 18:17 UTC |
JOHNSON FRANKLIN P JRDirector
|
Exercise / conversionCommon Stock | 18,400 | $7.67 | $141,162.96 |
DisclosureSEC source: 0001181431-05-002559 · rrd64401.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 898,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (FPJ 01.10.05) Does not include (i) 634,400 shares held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner, (ii) 4 units contractual contingent payment rights held as indirect ownership by the Partnership arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (iii) 822,888 shares held as indirect ownership by reporting person's spouse. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| December 31, 2004 Filed Jan 4, 2005 19:41 UTC |
SEIDENBERG BETH CSr VP, Dev & Chief Medical Ofc
|
Disposition to issuerCommon Stock | 5,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-000793 · rrd63282.xml · nonDerivative · entry 2 SEIDENBERG BETH C · CIK 0001184592 · Sr VP, Dev & Chief Medical Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,343 Read SEC document |
| December 31, 2004 Filed Jan 4, 2005 19:41 UTC |
SEIDENBERG BETH CSr VP, Dev & Chief Medical Ofc
|
Tax withholdingCommon Stock | 6,121 | $64.15 | $392,662.15 |
DisclosureSEC source: 0001181431-05-000793 · rrd63282.xml · nonDerivative · entry 1 SEIDENBERG BETH C · CIK 0001184592 · Sr VP, Dev & Chief Medical Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,720 Read SEC document |
| December 13, 2004 Filed Dec 15, 2004 23:25 UTC |
Dere Willard HSr. V.P., Global Dev & CMO
|
GrantNQSO (Right to Buy) · Derivative | 13,900 | $0.00 Strike: $63.95 | $0.00 |
DisclosureSEC source: 0001181431-04-059040 · rrd61441.xml · derivative · entry 1 Dere Willard H · CIK 0001311569 · Sr. V.P., Global Dev & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,900 Underlying: Common Stock · 13,900 shares Expires 2011-12-13 F1 · derivative.exercise_date: (WHD 12/04) This option becomes exercisable in four equal installments of 3,475 shares each commencing 12/13/2005. Read SEC document |
| December 09, 2004 Filed Dec 9, 2004 21:12 UTC |
OMENN GILBERT SDirector
|
GiftCommon Stock | 340 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-057726 · rrd60790.xml · nonDerivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 5,590 Read SEC document |
| December 09, 2004 Filed Dec 9, 2004 21:12 UTC |
OMENN GILBERT SDirector
|
GiftCommon Stock | 1,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-057726 · rrd60790.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,811 F1 · balance_after: (GSO-12.09.04) Does not include .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| December 06, 2004 Filed Dec 7, 2004 01:25 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-057058 · rrd60344.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| December 06, 2004 Filed Jan 12, 2005 18:37 UTC |
MARTIN TIMOTHY OVP, Control Plng & CAO
|
GrantCommon Stock | 5,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-002561 · rrd63990.xml · nonDerivative · entry 1 MARTIN TIMOTHY O · CIK 0001282020 · VP, Control Plng & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,350 Read SEC document |
| December 03, 2004 Filed Jan 7, 2005 00:05 UTC |
JOHNSON FRANKLIN P JRDirector
|
GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-001910 · rrd63962.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 822,888 Read SEC document |
| December 03, 2004 Filed Jan 7, 2005 00:05 UTC |
JOHNSON FRANKLIN P JRDirector
|
GiftCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-001910 · rrd63962.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 880,222 F1 · balance_after: (FPJ 12.03.04) Does not include (i) 634,400 shares held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner and (ii) 4 units contractual contingent payment rights held as indirect ownership by the Partnership arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 23, 2004 Filed Nov 23, 2004 22:52 UTC |
MORROW GEORGE JExe VP, Global Commercial Ops
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 59,998 | $0.00 Strike: $38.36 | $0.00 |
DisclosureSEC source: 0001181431-04-054794 · rrd59120.xml · derivative · entry 6 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,393 Underlying: Common Stock · 59,998 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: (GJM-07/02-NQSO) The option becomes exercisable for 29,999 shares on July 1, 2003; 29,999 shares on July 1, 2004; 29,999 shares on July 1, 2005; 30,000 shares on July 1, 2006; 27,394 shares on July 1, 2007; respectively. Read SEC document |
| November 23, 2004 Filed Nov 23, 2004 22:52 UTC |
MORROW GEORGE JExe VP, Global Commercial Ops
|
SaleCommon Stock | 15,000 | $59.55 | $893,250.00 |
DisclosureSEC source: 0001181431-04-054794 · rrd59120.xml · nonDerivative · entry 5 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| November 23, 2004 Filed Nov 23, 2004 22:52 UTC |
MORROW GEORGE JExe VP, Global Commercial Ops
|
SaleCommon Stock | 15,000 | $59.57 | $893,550.00 |
DisclosureSEC source: 0001181431-04-054794 · rrd59120.xml · nonDerivative · entry 4 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Read SEC document |
| November 23, 2004 Filed Nov 23, 2004 22:52 UTC |
MORROW GEORGE JExe VP, Global Commercial Ops
|
SaleCommon Stock | 15,000 | $59.60 | $894,000.00 |
DisclosureSEC source: 0001181431-04-054794 · rrd59120.xml · nonDerivative · entry 3 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Read SEC document |
| November 23, 2004 Filed Nov 23, 2004 22:52 UTC |
MORROW GEORGE JExe VP, Global Commercial Ops
|
SaleCommon Stock | 14,998 | $59.63 | $894,330.74 |
DisclosureSEC source: 0001181431-04-054794 · rrd59120.xml · nonDerivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Read SEC document |
| November 23, 2004 Filed Nov 23, 2004 22:52 UTC |
MORROW GEORGE JExe VP, Global Commercial Ops
|
Exercise / conversionCommon Stock | 59,998 | $38.36 | $2,301,523.28 |
DisclosureSEC source: 0001181431-04-054794 · rrd59120.xml · nonDerivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2004 Filed Nov 19, 2004 00:27 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-04-054055 · rrd58668.xml · derivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 27,896 Underlying: Common Stock · 20,000 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2004 Filed Nov 19, 2004 00:27 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
SaleCommon Stock | 20,000 | $59.99 | $1,199,800.00 |
DisclosureSEC source: 0001181431-04-054055 · rrd58668.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,752 F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| November 18, 2004 Filed Nov 19, 2004 20:58 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 15,000 | $60.20 | $903,000.00 |
DisclosureSEC source: 0001181431-04-054247 · rrd58666.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902,722 F1 · balance_after: (FPJ 11.12.04) Does not include (i) 4 units contractural contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners L.P., (ii) 634,400 shares held as indirect ownership by the Partnership for which the reporting person is a general partner, and (iii) 824,888 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of the securities held by the Partnership and his spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 12, 2004 Filed Nov 13, 2004 01:01 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 20,000 | $59.79 | $1,195,708.00 |
DisclosureSEC source: 0001181431-04-052594 · rrd57882.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 917,722 F1 · balance_after: (FPJ 11.12.04) Does not include (i) 4 units contractural contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., (ii) 634,400 shares held as indirect ownership by the Partnership for which the reporting person is a general partner, and (iii) 824,888 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of the securities held by the the Partnership and his spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 12, 2004 Filed Nov 13, 2004 01:01 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $59.68 | $596,832.00 |
DisclosureSEC source: 0001181431-04-052594 · rrd57882.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,722 F1 · balance_after: (FPJ 11.12.04) Does not include (i) 4 units contractural contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., (ii) 634,400 shares held as indirect ownership by the Partnership for which the reporting person is a general partner, and (iii) 824,888 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of the securities held by the the Partnership and his spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 12, 2004 Filed Nov 13, 2004 01:01 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $59.65 | $596,525.00 |
DisclosureSEC source: 0001181431-04-052594 · rrd57882.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947,722 F1 · balance_after: (FPJ 11.12.04) Does not include (i) 4 units contractural contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., (ii) 634,400 shares held as indirect ownership by the Partnership for which the reporting person is a general partner, and (iii) 824,888 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of the securities held by the the Partnership and his spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 12, 2004 Filed Nov 13, 2004 01:01 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 10,000 | $59.64 | $596,380.00 |
DisclosureSEC source: 0001181431-04-052594 · rrd57882.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 957,722 F1 · balance_after: (FPJ 11.12.04) Does not include (i) 4 units contractural contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., (ii) 634,400 shares held as indirect ownership by the Partnership for which the reporting person is a general partner, and (iii) 824,888 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of the securities held by the the Partnership and his spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 12, 2004 Filed Nov 13, 2004 01:01 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 7,600 | $59.58 | $452,793.56 |
DisclosureSEC source: 0001181431-04-052594 · rrd57882.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 967,722 F1 · balance_after: (FPJ 11.12.04) Does not include (i) 4 units contractural contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., (ii) 634,400 shares held as indirect ownership by the Partnership for which the reporting person is a general partner, and (iii) 824,888 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of the securities held by the the Partnership and his spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 12, 2004 Filed Nov 15, 2004 15:19 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
Exercise / conversionNQSO(Right to Buy) · Derivative | 20,000 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-04-052639 · rrd57900.xml · derivative · entry 4 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 47,896 Underlying: Common Stock · 20,000 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2004 Filed Nov 15, 2004 15:19 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
SaleCommon Stock | 20,000 | $59.12 | $1,182,312.00 |
DisclosureSEC source: 0001181431-04-052639 · rrd57900.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,752 F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| November 12, 2004 Filed Nov 15, 2004 15:19 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
Exercise / conversionCommon Stock | 20,000 | $16.38 | $327,500.00 |
DisclosureSEC source: 0001181431-04-052639 · rrd57900.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 127,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| November 12, 2004 Filed Nov 15, 2004 15:19 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
GiftCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-052639 · rrd57900.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,752 F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| November 12, 2004 Filed Nov 16, 2004 01:05 UTC |
MILETICH JOSEPH PSr VP Rsch & Preclinical Dev
|
SaleCommon Stock | 3,213 | $60.01 | $192,804.42 |
DisclosureSEC source: 0001181431-04-052959 · rrd58067.xml · nonDerivative · entry 1 MILETICH JOSEPH P · CIK 0001184125 · Sr VP Rsch & Preclinical Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Read SEC document |
| November 12, 2004 Filed Nov 16, 2004 16:58 UTC |
MCNAMEE BRIAN MSr. V.P.,Human Resources
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $38.36 | $0.00 |
DisclosureSEC source: 0001181431-04-053045 · rrd58060.xml · derivative · entry 3 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,394 Underlying: Common Stock · 20,000 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2004 Filed Nov 16, 2004 16:58 UTC |
MCNAMEE BRIAN MSr. V.P.,Human Resources
|
SaleCommon Stock | 40,000 | $59.69 | $2,387,648.00 |
DisclosureSEC source: 0001181431-04-053045 · rrd58060.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,506 F1 · balance_after: (BMM-11-BQSO) The option becomes excercisable for 20,000 shares on July 1, 2003; 20,000 shares on July 1, 2004; 20,000 shares on July 1, 2005; 20,000 shares on July 1, 2006; and 17,394 shares on July 1, 2007, respectively. Read SEC document |
| November 12, 2004 Filed Nov 16, 2004 16:58 UTC |
MCNAMEE BRIAN MSr. V.P.,Human Resources
|
Exercise / conversionCommon Stock | 40,000 | $38.36 | $1,534,400.00 |
DisclosureSEC source: 0001181431-04-053045 · rrd58060.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (BMM-11-BQSO) The option becomes excercisable for 20,000 shares on July 1, 2003; 20,000 shares on July 1, 2004; 20,000 shares on July 1, 2005; 20,000 shares on July 1, 2006; and 17,394 shares on July 1, 2007, respectively. Read SEC document |
| October 29, 2004 Filed Nov 1, 2004 17:59 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-04-049749 · rrd56183.xml · derivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 67,896 Underlying: Common Stock · 20,000 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.